Agreed. As far as I can make out we have been provided very...

Agreed. As far as I can make out we have been provided very little ( if any) information on MRI trials where the nanoparticles are hoped to produce better contrast imaging. I suspect this aspect of the R&D is what got Siemens Health interested in the first place to secure best position at the table so to speak if matters proceed to commercialization specific to MRI. I'm fairly sure I have not missed anything along the way so there seems a lack of information on progress on this aspect. Pretty much its the MRX trials that seem to take more prominence in communications. It would be appreciated if Geoff Hollis or someone could give an update on the MRI side of things and whether Siemens is still liaising with us in a pro-active sense or has this study been abandoned